Dr. Nigel Rawson is a pharmacoepidemiologist, pharmaceutical policy researcher, and President of Eastlake Research Group, a consulting company with a mission to create data-driven responses to pharmaceutical and health policy issues. He is also an Affiliated Scholar at the Canadian Health Policy Institute and a Senior Fellow with the Fraser Institute. He holds an MSc in statistics and a PhD in pharmacoepidemiology. Dr. Rawson was employed in academic research in the United Kingdom until the end of 1989 and subsequently held professorships at the University of Saskatchewan and Memorial University of Newfoundland. He has also been a senior researcher in United Health Group’s Center for Health Care Policy and Evaluation, where he collaborated with the FDA on drug safety studies, and GlaxoSmithKline’s only epidemiologist in Canada providing advice and analysis for current and developing medicines and vaccines. Dr. Rawson has performed epidemiologic studies of the use of drugs and their outcomes for over 30 years and published more than 100 book chapters and articles in peer-reviewed journals.